Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLCG1301: Daily vs alternate-day S-1 after resected stage I NSCLC
jRCTs061180082Phase 2Completed
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of tegafur in non-small cell lung cancer (NSCLC) (2 arms). Primary endpoint: Feasibility. Started Jan 2014; status: completed.
02
Drugs
tegafur
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on jRCTs061180082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061180082.